Format

Send to

Choose Destination
J BUON. 2019 Nov-Dec;24(6):2577.

Some concerns about adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer.

Author information

1
MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.
PMID:
31983136
Free full text

Supplemental Content

Full text links

Icon for Zerbinis, Medical Publications
Loading ...
Support Center